UnitedHealth Group Incorporated $UNH Shares Sold by M&G PLC

Posted by Geri Gentry on Nov 10th, 2026

M&G PLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 10.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 665,988 shares of the healthcare conglomerate’s stock after selling 79,299 shares during the quarter. UnitedHealth Group accounts for about 1.2% of M&G PLC’s portfolio, making the stock its 21st largest position. M&G PLC’s holdings in UnitedHealth Group were worth $244,418,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the stock. Nvwm LLC grew its holdings in UnitedHealth Group by 89.2% during the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 33 shares during the period. Wellington Altus USA Inc. raised its holdings in UnitedHealth Group by 97.1% in the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 33 shares during the period. Security National Bank of SO Dak bought a new position in shares of UnitedHealth Group during the second quarter worth $29,000. Compass Wealth Management LLC bought a new position in shares of UnitedHealth Group during the third quarter worth $29,000. Finally, Aberdeen Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $31,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $396.97 on Tuesday. The firm has a market capitalization of $355.70 billion, a price-to-earnings ratio of 22.67, a PEG ratio of 1.48 and a beta of 0.51. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The business’s 50-day moving average price is $390.68 and its 200-day moving average price is $364.28. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.72 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter last year, the firm posted $2.59 EPS. UnitedHealth Group’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s payout ratio is 53.00%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on UNH. Morgan Stanley raised their price target on UnitedHealth Group from $529.00 to $531.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 27th. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Jefferies Financial Group lifted their price target on shares of UnitedHealth Group from $401.00 to $490.00 and gave the company a “buy” rating in a research note on Friday, July 17th. Barclays dropped their price objective on shares of UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a report on Wednesday, October 14th. Finally, Weiss Ratings raised UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $463.93.

Read Our Latest Stock Analysis on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.

Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.